Non-Insurance revenue declined by 70% to $176.0 million compared to the third quarter 2022, as a result of our previously disclosed strategic shift, and Non-Insurance MCR was 104.1%. "We are proud to ...

Let’s dig into the relative performance of Clover Health (NASDAQ:CLOV) and its peers as we unravel the now-completed Q2 ...

Your browser does not support the video element. About a decade ago, a new breed of health insurer began to emerge. Armed with billions in venture capital, these ...

A crop of health insurance upstarts that went public in 2021 at sky-high valuations have long pursued more members at the expense of their bottom lines. Now that it's become harder to raise capital ...

Insurance revenue grew 17% compared to Q2'22, and second quarter Insurance MCR improved to 77.2%, bringing first half MCR to 81.9% Company reports Q2 Net Loss of $28.8 million, and Adjusted EBITDA ...

164,887 aligned Non-Insurance Beneficiaries. Membership and associated premiums earned and medical claim expenses. We define new and returning members on a calendar year basis. Any member who is ...